Effects of potential calcium sensing receptor inducers on promoting chemosensitivity of human colon carcinoma cells

International Journal of Oncology

Volumn 36, Issue 6, 2010, Pages 1573-1580

  Wang, Xize ^a   Wei, Chen ^a   Singh, Navneet ^b   Promkan, Multira ^b   Liu, Guangming ^b  

^a Northern Hospital   (China)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcipotriol; Calcium sensing receptor; Drug sensitivity; Human colon carcinoma cells; Lentinan

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BETA CATENIN; CALCIPOTRIOL; CALCIUM SENSING RECEPTOR; FLUOROURACIL; FOLINIC ACID; LENTINAN; PROTEIN TCF4; SURVIVIN; T CELL FACTOR PROTEIN; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; COLON CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALCITRIOL; CAMPTOTHECIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION; HUMANS; IMMUNOPRECIPITATION; LENTINAN; LEUCOVORIN; RECEPTORS, CALCIUM-SENSING; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 77951566131     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000644     Document Type: Article

References (37)

1. Brown EM, Pollak M and Hebert SC: The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 49: 15-29, 1998. (Pubitemid 28197438)
2. Rodland KD: The role of the calcium-sensing receptor in cancer. Cell Calcium 35: 291-295, 2004.
3. 2+-sensing receptor in the gastrointestinal tract. Cell Calcium 35: 239-247, 2004.
4. Larriba MJ and Munoz A: SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer 92: 985-989, 2005.
5. Kirchhoff P and Geibel JP: Role of calcium and other trace elements in the gastrointestinal physiology. World J Gastroenterol 12: 3229-3236, 2006. (Pubitemid 43881348)
6. Boman BM and Huang E: Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 26: 2828-2838, 2008.
7. Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H and Varani J: Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Cancer Res 65: 493-498, 2005.
8. 2+ in colon carcinoma is dependent on calcium-sensing receptor expression and function. Int J Cancer 121: 1455-1462, 2007.
9. Chakrabarty S, Radjendirane V, Appelman H and Varani J: Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res 63: 67-71, 2003. (Pubitemid 36070421)
10. Bhagavathula N, Kelley EA, Reddy M, Nerusu KC, Leonard C, Fay K, Chakrabarty S and Varani J: Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signaling in the regulation of growth and differentiation in colon carcinoma. Br J Cancer 93: 1364-1371, 2005. (Pubitemid 41752863)
11. Liu G, Hu X, Varani J and Chakrabarty S: Calcium and calcium sensing receptor modulates the expression of thymidylate synthase, NAD(P)H:quinone oxidoreductase 1 and survivin in human colon carcinoma cells: promotion of cytotoxic response to mitomycin C and fluorouracil. Mol Carcinog 48: 202-211, 2009.
12. Liu G, Hu X and Chakrabarty S: Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU. Int J Cancer 126: 631-639, 2010.
13. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF and Fuller F: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270: 12919-12925, 1995.
14. Chikatsu N, Fukumoto S, Takeuchi Y, Suzawa M, Obara T, Matsumoto T and Fujita T: Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J Biol Chem 272: 7553-7557, 2000. (Pubitemid 30159653)
15. Canaff L and Hendy GN: Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277: 30337-30350, 2002.
16. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S and Jurutka PW: Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66: S98-S112, 2008.
17. Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J and Sunga AY: Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 24: 219-224, 2009.
18. Cross HS, Lipkin M and Kállay E: Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 136: 561-564, 2006. (Pubitemid 43363735)
19. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK and Gorham ED: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178, 1989. (Pubitemid 19275448)
20. Saraceno R andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A and Chimenti S: Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. J Dermatolog Treat 18: 361-365, 2007.
21. Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5: 4-27, 2000. (Pubitemid 30132069)
22. Zajickova K, Vrbikova J, Canaff L, Pawelek PD, Goltzman D and Hendy GN: Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab 92: 2616-2623, 2007. (Pubitemid 47037366)
23. Ling X, Bernacki RJ, Brattain MG and Li F: Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. J Biol Chem 279: 15196-15203, 2004. (Pubitemid 38618915)
24. Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ and Ladner RD: A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 63: 2898-2904, 2003. (Pubitemid 36667162)
25. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
26. Liu G, Bode A, Ma WY, Sang S, Ho CT and Dong Z: Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 61: 5749-5756, 2001. (Pubitemid 32769090)
27. Popat J, Matakidou A and Houlston RS: Thymidylate synthase expression and prognosis in colorectal cancer: a systemic review and meta-analysis. J Clin Oncol 22: 529-636, 2004. (Pubitemid 41079782)
28. Notarbartolo M, Cervello M, Poma P, Dusonchet L, Meli M and Dalessandro N: Expression of the IAPs in multidrug resistant tumor cells. Oncol Rep 11: 133-136, 2004.
29. Altieri DC: Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5: 447-452, 2003.
30. Ferrario A, Rucker N, Wong S, Luna M and Gomer CJ: Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res 67: 4989-4995, 2007. (Pubitemid 46910208)
31. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584, 1998. (Pubitemid 28563719)
32. Marsh S: Thymidylate synthase pharmacogenetics. Invest New Drugs 23: 533-537, 2005.
33. Danenberg PV: Pharmacogenomics of thymidylate synthase in cancer treatment. Front Biosci 9: 2484-2494, 2004.
34. Chu E, Callender MA, Farrell MP and Schmitz JC: Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemother Pharmacol 52: S80-S89, 2003.
35. Rose MG, Farrell MP and Schmitz JC: Thymidylate synthase: a critical target for cancer chemotherapy. Clin Colorectal Cancer 1: 220-229, 2002. (Pubitemid 34269382)
36. Whitfield JF: Calcium, calcium-sensing receptor and colon cancer. Cancer Lett 275: 9-16, 2009.
37. MacLeod RJ, Hayes M and Pacheco I: Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 293: G403-G411, 2007. (Pubitemid 47105201)